Abstract
Thyroid storm (TS) is a rare and life-threatening medical emergency, most commonly caused by Graves' disease (GD). GD can be induced by immune reconstitution therapy (IRT) such as alemtuzumab (ALZ), a humanized monoclonal antibody against CD52, which is shown to be effective in the treatment of relapsing-remitting multiple sclerosis (RRMS). Here, we present a rare case of TS developing in a 39-year-old female with ALZ-induced GD, managed with antithyroid medication followed by thyroidectomy. There is some evidence that ALZ-induced GD may behave less aggressively than conventional GD. However, physicians should be aware that severe thyrotoxicosis and thyroid storm can happen, which requires prompt recognition and aggressive therapy.
Cite
CITATION STYLE
AlShehri, S., Alajmi, S., Ekhzaimy, A., Aldawas, S., & Alalwan, M. (2022). Thyroid Storm in a Patient With Alemtuzumab-Induced Graves’ Disease: A Case Report. Cureus. https://doi.org/10.7759/cureus.24570
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.